Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was EGP 429.79 million compared to EGP 302.65 million a year ago. Net income was EGP 82.89 million compared to EGP 27.56 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
79.64 EGP | -0.80% | -16.39% | +27.00% |
1st Jan change | Capi. | |
---|---|---|
+27.00% | 9.52M | |
+30.92% | 682B | |
+30.35% | 586B | |
-3.58% | 364B | |
+18.12% | 327B | |
+4.08% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.43% | 165B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023